316 related articles for article (PubMed ID: 12476445)
1. Communication with close and distant relatives in the context of genetic testing for hereditary breast and ovarian cancer in cancer patients.
Claes E; Evers-Kiebooms G; Boogaerts A; Decruyenaere M; Denayer L; Legius E
Am J Med Genet A; 2003 Jan; 116A(1):11-9. PubMed ID: 12476445
[TBL] [Abstract][Full Text] [Related]
2. Men at risk of being a mutation carrier for hereditary breast/ovarian cancer: an exploration of attitudes and psychological functioning during genetic testing.
Lodder L; Frets PG; Trijsburg RW; Tibben A; Meijers-Heijboer EJ; Duivenvoorden HJ; Wagner A; van Der Meer CA; Devilee P; Cornelisse CJ; Niermeijer MF
Eur J Hum Genet; 2001 Jul; 9(7):492-500. PubMed ID: 11464240
[TBL] [Abstract][Full Text] [Related]
3. BRCA1/2 testing in hereditary breast and ovarian cancer families II: impact on relationships.
McInerney-Leo A; Biesecker BB; Hadley DW; Kase RG; Giambarresi TR; Johnson E; Lerman C; Struewing JP
Am J Med Genet A; 2005 Mar; 133A(2):165-9. PubMed ID: 15633195
[TBL] [Abstract][Full Text] [Related]
4. BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes.
Lerman C; Narod S; Schulman K; Hughes C; Gomez-Caminero A; Bonney G; Gold K; Trock B; Main D; Lynch J; Fulmore C; Snyder C; Lemon SJ; Conway T; Tonin P; Lenoir G; Lynch H
JAMA; 1996 Jun; 275(24):1885-92. PubMed ID: 8648868
[TBL] [Abstract][Full Text] [Related]
5. Communication of BRCA1 and BRCA2 results to at-risk relatives: a cancer risk assessment program's experience.
Wagner Costalas J; Itzen M; Malick J; Babb JS; Bove B; Godwin AK; Daly MB
Am J Med Genet C Semin Med Genet; 2003 May; 119C(1):11-8. PubMed ID: 12704633
[TBL] [Abstract][Full Text] [Related]
6. BRCA1/2 testing in hereditary breast and ovarian cancer families: effectiveness of problem-solving training as a counseling intervention.
McInerney-Leo A; Biesecker BB; Hadley DW; Kase RG; Giambarresi TR; Johnson E; Lerman C; Struewing JP
Am J Med Genet A; 2004 Oct; 130A(3):221-7. PubMed ID: 15378542
[TBL] [Abstract][Full Text] [Related]
7. Differences between women who pursued genetic testing for hereditary breast and ovarian cancer and their at-risk relatives who did not.
Katapodi MC; Northouse L; Pierce P; Milliron KJ; Liu G; Merajver SD
Oncol Nurs Forum; 2011 Sep; 38(5):572-81. PubMed ID: 21875844
[TBL] [Abstract][Full Text] [Related]
8. Experiences of BRCA1/2 Gene Mutation-Positive Women With Cancer in Communicating Genetic Risk to Their Relatives.
Seven M; Shah LL; Daack-Hirsch S; Yazici H
Cancer Nurs; 2021 May-Jun 01; 44(3):E142-E150. PubMed ID: 32022782
[TBL] [Abstract][Full Text] [Related]
9. BRCA1 in the family: a case description of the psychological implications.
DudokdeWit AC; Tibben A; Frets PG; Meijers-Heijboer EJ; Devilee P; Klijn JG; Oosterwijk JC; Niermeijer MF
Am J Med Genet; 1997 Jul; 71(1):63-71. PubMed ID: 9215771
[TBL] [Abstract][Full Text] [Related]
10. Communication about positive BRCA1 and BRCA2 genetic test results and uptake of testing in relatives in a diverse Asian setting.
Lee DS; Meiser B; Mariapun S; Hassan T; Yip CH; Mohd Taib NA; Teo SH; Thong MK; Yoon SY
J Genet Couns; 2021 Jun; 30(3):720-729. PubMed ID: 33245177
[TBL] [Abstract][Full Text] [Related]
11. Uptake of predictive testing among relatives of BRCA1 and BRCA2 families: a multicenter study in northeastern Spain.
Sanz J; Ramón y Cajal T; Torres A; Darder E; Gadea N; Velasco A; Fortuny D; López C; Fisas D; Brunet J; Alonso MC; Balmaña J
Fam Cancer; 2010 Sep; 9(3):297-304. PubMed ID: 20091130
[TBL] [Abstract][Full Text] [Related]
12. A descriptive study of BRCA1 testing and reactions to disclosure of test results.
Lynch HT; Lemon SJ; Durham C; Tinley ST; Connolly C; Lynch JF; Surdam J; Orinion E; Slominski-Caster S; Watson P; Lerman C; Tonin P; Lenoir G; Serova O; Narod S
Cancer; 1997 Jun; 79(11):2219-28. PubMed ID: 9179070
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic genetic testing for hereditary breast and ovarian cancer in cancer patients: women's looking back on the pre-test period and a psychological evaluation.
Claes E; Evers-Kiebooms G; Boogaerts A; Decruyenaere M; Denayer L; Legius E
Genet Test; 2004; 8(1):13-21. PubMed ID: 15140370
[TBL] [Abstract][Full Text] [Related]
14. Preparing individuals to communicate genetic test results to their relatives: report of a randomized control trial.
Montgomery SV; Barsevick AM; Egleston BL; Bingler R; Ruth K; Miller SM; Malick J; Cescon TP; Daly MB
Fam Cancer; 2013 Sep; 12(3):537-46. PubMed ID: 23420550
[TBL] [Abstract][Full Text] [Related]
15. Women's satisfaction with genetic counseling for hereditary breast-ovarian cancer: psychological aspects.
Tercyak KP; Demarco TA; Mars BD; Peshkin BN
Am J Med Genet A; 2004 Nov; 131(1):36-41. PubMed ID: 15389697
[TBL] [Abstract][Full Text] [Related]
16. Clinical Actionability of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Risk Assessment.
Desmond A; Kurian AW; Gabree M; Mills MA; Anderson MJ; Kobayashi Y; Horick N; Yang S; Shannon KM; Tung N; Ford JM; Lincoln SE; Ellisen LW
JAMA Oncol; 2015 Oct; 1(7):943-51. PubMed ID: 26270727
[TBL] [Abstract][Full Text] [Related]
17. Genetic uptake in BRCA-mutation families is related to emotional and behavioral communication characteristics of index patients.
Landsbergen K; Verhaak C; Kraaimaat F; Hoogerbrugge N
Fam Cancer; 2005; 4(2):115-9. PubMed ID: 15951961
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms to increase cascade testing in hereditary breast and ovarian cancer: Impact of introducing standardized communication aids into genetic counseling.
Garcia C; Sullivan MW; Lothamer H; Harrison KM; Chatfield L; Thomas MH; Modesitt SC
J Obstet Gynaecol Res; 2020 Sep; 46(9):1835-1841. PubMed ID: 32656916
[TBL] [Abstract][Full Text] [Related]
19. Attitudes and distress levels in women at risk to carry a BRCA1/BRCA2 gene mutation who decline genetic testing.
Lodder L; Frets PG; Trijsburg RW; Klijn JG; Seynaeve C; Tilanus MM; Bartels CC; Meijers-Heijboer EJ; Verhoog LC; Niermeijer MF
Am J Med Genet A; 2003 Jun; 119A(3):266-72. PubMed ID: 12784290
[TBL] [Abstract][Full Text] [Related]
20. Cancer patients who experienced diagnostic genetic testing for cancer susceptibility: reactions and behavior after the disclosure of a positive test result.
Bonadona V; Saltel P; Desseigne F; Mignotte H; Saurin JC; Wang Q; Sinilnikova O; Giraud S; Freyer G; Plauchu H; Puisieux A; Lasset C
Cancer Epidemiol Biomarkers Prev; 2002 Jan; 11(1):97-104. PubMed ID: 11815406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
